These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22905254)

  • 1. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey.
    Dorman SE; Chihota VN; Lewis JJ; Shah M; Clark D; Grant AD; Churchyard GJ; Fielding KL
    PLoS One; 2012; 7(8):e43307. PubMed ID: 22905254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.
    Kurbatova EV; Kaminski DA; Erokhin VV; Volchenkov GV; Andreevskaya SN; Chernousova LN; Demikhova OV; Ershova JV; Kaunetis NV; Kuznetsova TA; Larionova EE; Smirnova TG; Somova TR; Vasilieva IA; Vorobieva AV; Zolkina SS; Cegielski JP
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):735-43. PubMed ID: 23263819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility.
    Geleta DA; Megerssa YC; Gudeta AN; Akalu GT; Debele MT; Tulu KD
    BMC Microbiol; 2015 Oct; 15():220. PubMed ID: 26483194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
    Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
    J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Dorman SE; Schumacher SG; Alland D; Nabeta P; Armstrong DT; King B; Hall SL; Chakravorty S; Cirillo DM; Tukvadze N; Bablishvili N; Stevens W; Scott L; Rodrigues C; Kazi MI; Joloba M; Nakiyingi L; Nicol MP; Ghebrekristos Y; Anyango I; Murithi W; Dietze R; Lyrio Peres R; Skrahina A; Auchynka V; Chopra KK; Hanif M; Liu X; Yuan X; Boehme CC; Ellner JJ; Denkinger CM;
    Lancet Infect Dis; 2018 Jan; 18(1):76-84. PubMed ID: 29198911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.
    Matabane MM; Ismail F; Strydom KA; Onwuegbuna O; Omar SV; Ismail N
    BMC Infect Dis; 2015 Nov; 15():508. PubMed ID: 26553046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.